tert-Butyl 3-bromo-4-hydroxy-4-(trifluoromethyl)piperidine-1-carboxylate
97%
- Product Code: 124204
CAS:
2101206-52-2
| Molecular Weight: | 348.16 g./mol | Molecular Formula: | C₁₁H₁₇BrF₃NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28975667 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in organic synthesis as a versatile intermediate for the development of pharmaceuticals and agrochemicals. Its structure, featuring a trifluoromethyl group and a bromo substituent, makes it valuable for constructing complex molecules, particularly in the synthesis of bioactive compounds. The tert-butyloxycarbonyl (Boc) protecting group ensures stability during reactions, allowing selective modifications to the piperidine ring. It is often employed in medicinal chemistry for the design of drug candidates targeting neurological disorders, inflammation, or infectious diseases, leveraging its ability to enhance pharmacokinetic properties. Additionally, the bromo group serves as a reactive site for further functionalization through cross-coupling reactions, enabling the creation of diverse chemical libraries for drug discovery.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $438.93 |
+
-
|
| 0.250 | 10-20 days | $745.86 |
+
-
|
| 1.000 | 10-20 days | $2,012.91 |
+
-
|
tert-Butyl 3-bromo-4-hydroxy-4-(trifluoromethyl)piperidine-1-carboxylate
This compound is primarily utilized in organic synthesis as a versatile intermediate for the development of pharmaceuticals and agrochemicals. Its structure, featuring a trifluoromethyl group and a bromo substituent, makes it valuable for constructing complex molecules, particularly in the synthesis of bioactive compounds. The tert-butyloxycarbonyl (Boc) protecting group ensures stability during reactions, allowing selective modifications to the piperidine ring. It is often employed in medicinal chemistry for the design of drug candidates targeting neurological disorders, inflammation, or infectious diseases, leveraging its ability to enhance pharmacokinetic properties. Additionally, the bromo group serves as a reactive site for further functionalization through cross-coupling reactions, enabling the creation of diverse chemical libraries for drug discovery.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :